Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
PLEASANTON, Calif., Feb. 28, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida. Mr. Kennedy is scheduled to present on Monday, March 6th at 7:30 a.m. Eastern Time (4:30 a.m. PT).
Investors may listen to a live webcast and view a copy of the slide presentation online via the “Investors” section of the Company’s web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days.
About Natus Medical
Natus is a leading provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President Finance and Chief Financial Officer (925) 223-6700 [email protected]
